DRG Epidemiology’s coverage of celiac disease comprises epidemiological estimates of key patient populations across the mature markets (the United States, France, Germany, Italy, Spain and the United Kingdom). We report the total prevalence of celiac disease for each country, as well as annualized case counts projected to the national population.

Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered in this report.

DRG Epidemiology’s celiac disease forecast will answer the following questions:

  • In the general population, how many in each country are living with celiac disease
  • Of all people with celiac disease, how many in each country have been formally diagnosed?

All forecast data are available on the DRG Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is provided for full transparency into research and methods.

Note: Coverage may vary by country.

Table of contents

  • Celiac Disease - Epidemiology - Mature Markets
    • Introduction
      • Key Findings
      • Total Prevalence of Celiac Disease per 100 Among People of All Ages in 2020 and 2040
      • Relative Sizes of the Factors Contributing to the Trend in Total Prevalent Cases of Celiac Disease over the Next Twenty Years
      • Analysis of the Total Prevalent Cases of Celiac Disease in 2020 by Diagnosis Status
      • Number of Additional Total Prevalent Cases of Celiac Disease in 2040 Across the Countries Under Study Due to Trends in Risk or Survival
    • Epidemiology Data
    • Methods
      • Total Prevalence
      • Percentage Diagnosed
    • Reference Materials
      • Literature Review
        • Studies Included in the Analysis of Celiac Disease
        • Studies Excluded from the Analysis of Celiac Disease
      • Risk/Protective Factors
        • Bibliography

      Author(s): Abey John, MPH; Sunali D. Goonesekera, SM

      Abey John is a medical graduate with a Master’s in Public Health and has been associated with DRG since September 2015. He works with a global team of epidemiologists in performing systematic reviews of assigned diseases and prepare forecast models for clients. He also is involved in producing analyses for pharmaceutical drug developers on the descriptive epidemiology of major drug indications in mature and developing markets and have an overall experience of three years working in different healthcare sectors across the country.

      Prior to joining DRG, Abey had been working with Jhpiego (an affiliate of Johns Hopkins Medical University) in implementing Family Planning Health Programs in India with collaborating with the Government of India. He also has worked with a grassroots level NGO as a health team manager which worked for the benefit of the rural population living in the foothills of the Himalayas.

      Sunali Goonesekera is an Associate Epidemiologist at Decision Resources Group.

      Sunali holds a Master’s degree in Epidemiology from the Harvard School of Public Health and a B.A. in Biology (Honors) from Dartmouth College. Prior to joining Decision Resources Group, Sunali conducted epidemiological research and lead authored two manuscripts on racial/ethnic disparities in metabolic diseases at the New England Research Institutes. She has contributed to multiple publications in peer-reviewed journals in epidemiology and in the biological sciences.